YZYBIO-B Reports Annual Performance: Net Loss Narrows 13.18% to 84.73 Million Yuan

Stock News

Mar 27

YZYBIO-B (02496) announced its annual results for the period ending December 31, 2025. The group recorded revenue of 66.858 million yuan, representing a decrease of 37.99% compared to the previous year. The net loss for the year was 84.732 million yuan, narrowing by 13.18% year-on-year. The basic loss per share was 0.44 yuan.

According to the announcement, the reduction in the group's loss during the reporting period was primarily due to a decrease in revenue of 41.00 million yuan, an increase in cost of revenue of 33.40 million yuan compared to the same period last year, and a decrease in research and development expenses of 86.80 million yuan compared to the same period. The combined effect of these factors resulted in a reduction in the total loss and comprehensive expenses for the reporting period compared to the same period last year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1115270281"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1115270281\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1115270281?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 21:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115270281","market":"other","top_or_hot":-1,"title":"YZYBIO-B Reports Annual Performance: Net Loss Narrows 13.18% to 84.73 Million Yuan","media":"Stock News","content":"<p>YZYBIO-B (02496) announced its annual results for the period ending December 31, 2025. The group recorded revenue of 66.858 million yuan, representing a decrease of 37.99% compared to the previous year. The net loss for the year was 84.732 million yuan, narrowing by 13.18% year-on-year. The basic loss per share was 0.44 yuan.</p>\n<p>According to the announcement, the reduction in the group's loss during the reporting period was primarily due to a decrease in revenue of 41.00 million yuan, an increase in cost of revenue of 33.40 million yuan compared to the same period last year, and a decrease in research and development expenses of 86.80 million yuan compared to the same period. The combined effect of these factors resulted in a reduction in the total loss and comprehensive expenses for the reporting period compared to the same period last year.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>YZYBIO-B Reports Annual Performance: Net Loss Narrows 13.18% to 84.73 Million Yuan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYZYBIO-B Reports Annual Performance: Net Loss Narrows 13.18% to 84.73 Million Yuan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-27 21:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>YZYBIO-B (02496) announced its annual results for the period ending December 31, 2025. The group recorded revenue of 66.858 million yuan, representing a decrease of 37.99% compared to the previous year. The net loss for the year was 84.732 million yuan, narrowing by 13.18% year-on-year. The basic loss per share was 0.44 yuan.</p>\n<p>According to the announcement, the reduction in the group's loss during the reporting period was primarily due to a decrease in revenue of 41.00 million yuan, an increase in cost of revenue of 33.40 million yuan compared to the same period last year, and a decrease in research and development expenses of 86.80 million yuan compared to the same period. The combined effect of these factors resulted in a reduction in the total loss and comprehensive expenses for the reporting period compared to the same period last year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1115270281","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115270281","pubTimestamp":1774618578,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"YZYBIO-B (02496) announced its annual results for the period ending December 31, 2025. The group recorded revenue of 66.858 million yuan, representing a decrease of 37.99% compared to the previous...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","02496":"友芝友生物-B"},"translate_title":"益智生物-B年报业绩：净亏损收窄13.18%至8473万元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02496":1},"content_text":"YZYBIO-B (02496) announced its annual results for the period ending December 31, 2025. The group recorded revenue of 66.858 million yuan, representing a decrease of 37.99% compared to the previous year. The net loss for the year was 84.732 million yuan, narrowing by 13.18% year-on-year. The basic loss per share was 0.44 yuan.\nAccording to the announcement, the reduction in the group's loss during the reporting period was primarily due to a decrease in revenue of 41.00 million yuan, an increase in cost of revenue of 33.40 million yuan compared to the same period last year, and a decrease in research and development expenses of 86.80 million yuan compared to the same period. The combined effect of these factors resulted in a reduction in the total loss and comprehensive expenses for the reporting period compared to the same period last year.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}